HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 34 filers reported holding HARPOON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $53,000 | -41.1% | 10,723 | -10.0% | 0.00% | – |
| Q4 2021 | $90,000 | +1.1% | 11,921 | +5.2% | 0.00% | – |
| Q3 2021 | $89,000 | -64.5% | 11,329 | -37.4% | 0.00% | – |
| Q2 2021 | $251,000 | -22.8% | 18,102 | +16.5% | 0.00% | – |
| Q1 2021 | $325,000 | +34.9% | 15,535 | +7.2% | 0.00% | – |
| Q4 2020 | $241,000 | +138.6% | 14,494 | +144.0% | 0.00% | – |
| Q3 2020 | $101,000 | +12.2% | 5,940 | +9.3% | 0.00% | – |
| Q2 2020 | $90,000 | +246.2% | 5,436 | +136.7% | 0.00% | – |
| Q1 2020 | $26,000 | -54.4% | 2,297 | -41.9% | 0.00% | – |
| Q4 2019 | $57,000 | +111.1% | 3,955 | +91.0% | 0.00% | – |
| Q3 2019 | $27,000 | -53.4% | 2,071 | -54.9% | 0.00% | – |
| Q2 2019 | $58,000 | +107.1% | 4,591 | +45.2% | 0.00% | – |
| Q1 2019 | $28,000 | – | 3,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,130,267 | $43,417,000 | 8.07% |
| MPM BioImpact LLC | 3,196,707 | $44,338,000 | 7.28% |
| Aquilo Capital Management, LLC | 712,674 | $9,885,000 | 2.57% |
| Logos Global Management LP | 800,000 | $11,096,000 | 0.93% |
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $3,364,000 | 0.86% |
| VR Adviser, LLC | 512,005 | $7,102,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 580,759 | $8,055,000 | 0.65% |
| Avidity Partners Management LP | 1,500,000 | $20,805,000 | 0.56% |
| Orbimed Advisors | 2,611,308 | $36,219,000 | 0.37% |
| Maven Securities LTD | 618,610 | $8,456,000 | 0.34% |